法律人 LawPlayer logo

資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex

Decision

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

CELEX
Regulation (EC) No 258/97
Date of document
Articles
5
Source
EUR-Lex
Article 1

Lipid extract from Antarctic Krill Euphausia superba as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for the uses and at the maximum levels as listed in Annex II.

Article 2

The designation ‘lipid extract from the crustacean Antarctic Krill Euphausia superba ’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.

Article 3

This Decision is addressed to Neptune Technologies & Bioressources Inc., 225 Promenade du Centropolis, Suite 200, Laval, Quebec H7T 0B3, Canada.

Schedules & Appendices

ANNEX I

ANNEX I

SPECIFICATION OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA

Description

To produce lipid extract from Antarctic Krill Euphausia superba deep-frozen Antarctic krill is crushed and subjected to an extraction with acetone. Proteins and krill material are removed from the lipid extract by filtration. The acetone and residual water are removed by evaporation.

Test

Specification

Saponification value

Not more than 185 mg KOH/g

Peroxide value (PV)

Not more than 0,2 meq O 2 /kg oil

Moisture and volatiles

Not more than 0,9 %

Phospholipids

Not more than 50 %

Trans-fatty acids

Not more than 1 %

EPA (eicosapentaenoic acid)

Not less than 15 %

DHA (docosahexaenoic acid)

Not less than 7 %

ANNEX II

ANNEX II

USES OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA

Use group

Maximum content of combined DHA and EPA

Dairy products except milk-based drinks

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Spreadable fat and dressings

600 mg/100 g

Breakfast cereals

500 mg/100 g

Food supplements

200 mg per daily dose as recommended by the manufacturer

Dietary foods for special medical purposes

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Foods intended for use in energy restricted diets for weight reduction

200 mg/meal replacement

5 articles

Cite this act

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32009D0752

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

EU-EurLex-Reuse-2011-833

本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com